title: New therapies, increased risk for old infections--abdominal tuberculosis mimicking colon cancer during adalimumab treatment for rheumatoid arthritis.
authors.forename: Cosmin
authors.initials: C
authors.lastname: Dascalu
authors.forename: Adina
authors.initials: A
authors.lastname: Valceanu
authors.forename: Debra
authors.initials: D
authors.lastname: Brennessel
authors.forename: Sabiha
authors.initials: S
authors.lastname: Bandagi
mesh_terms: D000068879:Adalimumab; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000150:complications* / Q000188:drug therapy*; D003110:Colonic Neoplasms / Q000175:diagnosis; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D014395:Peritonitis, Tuberculous / Q000175:diagnosis* / Q000188:drug therapy; D012307:Risk Factors
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D000995:Antitubercular Agents; D000068879:Adalimumab; D008727:Methotrexate